TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
KURT ORESHACK, the General Counsel of $MRVI, sold 25,000 shares of the company on 01-31-2025 for an estimated $125,750. We received data on the trade from a recent ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a leading provider of critical products to enable the development of drug therapies, diagnostics, and novel vaccines, has ...
Zacks.com on MSN1d
MCK Stock Before Q3 Earnings: A Smart Buy or Risky Investment?McKesson Corporation MCK is scheduled to report third-quarter fiscal 2025 results on Feb. 5, after market close. The company ...
Prudent Investment Analysis requires observations of the support and resistance levels for Maravai Lifesciences Holdings Inc. (NASDAQ: MRVI) too. These define prudent trading plans. This is a static ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback